Literaturverzeichnis der PraxisLeitlinie:

Kernwissen zu Diagnostik und Behandlung von Migräne für Gynäkologinnen und Gynäkologen


 

1 Alemany S, Avella-García C, Liew Z, García-Esteban R, Inoue K, Cadman T, López-Vicente M, González L, Riaño Galán I, Andiarena A, Casas M, Margetaki K, Strandberg-Larsen K, Lawlor DA, El Marroun H, Tiemeier H, Iñiguez C, Tardón A, Santa-Marina L, Júlvez J, Porta D, Chatzi L, Sunyer J. Prenatal and postnatal ex-posure to acetaminophen in relation to autism spectrum and attention-deficit and hyperactivity symptoms in childhood: Meta-analysis in six European popula-tion-based cohorts. Eur J Epidemiol. 2021 Oct;36(10):993-1004. (1++)
2 Arumugam M, Parthasarathy V. Increased incidence of migraine in women corre-lates with obstetrics and gynaecological surgical procedures. Int J Surg. 2015 Oct;22:105-9. (2+)
3 Ashina M, Katsarava Z, Do TP, Buse DC, Pozo-Rosich P, Özge A, Krymchantowski AV, Lebedeva ER, Ravishankar K, Yu S, Sacco S, Ashina S, Younis S, Steiner TJ, Lipton RB. Migraine: epidemiology and systems of care. Lancet. 2021 Apr 17;397(10283):1485-1495.  (1++)
4 Aukes AM, Yurtsever FN, Boutin A, Visser MC, de Groot CJM. Associations Be-tween Migraine and Adverse Pregnancy Outcomes: Systematic Review and Meta-analysis. Obstet Gynecol Surv. 2019 Dec;74(12):738-748. (1++)
5 Blau JN. Migraine: theories of pathogenesis. Lancet. 1992 May 16;339(8803):1202-7. (3-)
6 Boese AC, Kim SC, Yin KJ, Lee JP, Hamblin MH. Sex differences in vascular physi-ology and pathophysiology: estrogen and androgen signaling in health and dis-ease. Am J Physiol Heart Circ Physiol. 2017 Sep 1;313(3):H524-H545. (1++)
7 Buse DC, Reed ML, Fanning KM, Bostic R, Dodick DW, Schwedt TJ, Munjal S, Singh P, Lipton RB. Comorbid and co-occurring conditions in migraine and asso-ciated risk of increasing headache pain intensity and headache frequency: re-sults of the migraine in America symptoms and treatment (MAST) study. J Heada-che Pain. 2020 Mar 2;21(1):23. (2++)
8 Champaloux SW, Tepper NK, Monsour M, Curtis KM, Whiteman MK, Marchbanks PA, Jamieson DJ. Use of combined hormonal contraceptives among women with migraines and risk of ischemic stroke. Am J Obstet Gynecol. 2017 May;216(5):489.e1-489.e7. (2++)
9 Chang CL, Donaghy M, Poulter N. Migraine and stroke in young women: case-control study. The World Health Organisation Collaborative Study of Cardiovas-cular Disease and Steroid Hormone Contraception. BMJ. 1999 Jan 2;318(7175):13-8. (2++)
10 Cornil CA, Ball GF, Balthazart J. Functional significance of the rapid regulation of brain estrogen action: where do the estrogens come from? Brain Res. 2006 Dec 18;1126(1):2-26. (1++)
11 Diener H.-C., Förderreuther S, Kropp P. et al., Therapie der Migräneattacke und Prophylaxe der Migräne, S1-Leitlinie, 2022, DGN und DMKG, in: Deutsche Ge-sellschaft für Neurologie (Hrsg.), Leitlinien für Diagnostik und Therapie in der Neurologie. Online: www.dgn.org/leitlinien (abgerufen am 18.04.2024)  (1++)
12 Diener H.-C., Förderreuther S, Kropp P. et al., Therapie der Migräneattacke und Prophylaxe der Migräne, S1-Leitlinie, 2022, DGN und DMKG, in: Deutsche Ge-sellschaft für Neurologie (Hrsg.), Leitlinien für Diagnostik und Therapie in der Neurologie. Online: www.dgn.org/leitlinien (abgerufen am 18.04.2024)  (1++, 4-)
13 Diener H.-C., Förderreuther S, Kropp P. et al., Therapie der Migräneattacke und Prophylaxe der Migräne, S1-Leitlinie, 2022, DGN und DMKG, in: Deutsche Ge-sellschaft für Neurologie (Hrsg.), Leitlinien für Diagnostik und Therapie in der Neurologie. Online: www.dgn.org/leitlinien (abgerufen am 18.04.2024)  (3-)
14 Diener H.-C., Förderreuther S, Kropp P. et al., Therapie der Migräneattacke und Prophylaxe der Migräne, S1-Leitlinie, 2022, DGN und DMKG, in: Deutsche Ge-sellschaft für Neurologie (Hrsg.), Leitlinien für Diagnostik und Therapie in der Neurologie. Online: www.dgn.org/leitlinien (abgerufen am 18.04.2024)  (4-)
15 Diener H.-C., Förderreuther S, Kropp P. et al., Therapie der Migräneattacke und Prophylaxe der Migräne, S1-Leitlinie, 2022, DGN und DMKG, in: Deutsche Ge-sellschaft für Neurologie (Hrsg.), Leitlinien für Diagnostik und Therapie in der Neurologie. Online: www.dgn.org/leitlinien (abgerufen am 18.04.2024) (1++)
16 Diener H.-C., Förderreuther S, Kropp P. et al., Therapie der Migräneattacke und Prophylaxe der Migräne, S1-Leitlinie, 2022, DGN und DMKG, in: Deutsche Ge-sellschaft für Neurologie (Hrsg.), Leitlinien für Diagnostik und Therapie in der Neurologie. Online: www.dgn.org/leitlinien (abgerufen am 18.04.2024) (4-)
17 Ertem DH, Ayan Saatçioğlu Ş, Bingol A, Mercan Ö, Erdogan G, Kokar S, Saglam H, Uluduz D. Factors influencing sexual functions in Turkish female patients with migraine. Agri. 2020 Nov;32(4):193-201. (2+)
18 Facchinetti F, Martignoni E, Gallai V, Micieli G, Petraglia F, Nappi G, Genazzani AR. Neuroendocrine evaluation of central opiate activity in primary headache disorders. Pain. 1988 Jul;34(1):29-33. (2+)
19 Ferrero S, Pretta S, Bertoldi S, Anserini P, Remorgida V, Del Sette M, Gandolfo C, Ragni N. Increased frequency of migraine among women with endometriosis. Hum Reprod. 2004 Dec;19(12):2927-32. (2++)
20 GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017 Sep 16;390(10100):1211-1259. doi: 10.1016/S0140-6736(17)32154-2. Erratum in: Lancet. 2017 Oct 28;390(10106) (1++)
21 GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019 May;18(5):459-480. (1++)
22 Giri S, Tronvik EA, Hagen K. The bidirectional temporal relationship between headache and affective disorders: longitudinal data from the HUNT studies. J Headache Pain. 2022 Jan 21;23(1):14. (2++)
23 Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S. Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiol Rev. 2017 Apr;97(2):553-622.  (1++)
24 Granella F, Sances G, Pucci E, Nappi RE, Ghiotto N, Napp G. Migraine with aura and reproductive life events: a case control study. Cephalalgia. 2000 Oct;20(8):701-7 (2+)
25 Göbel CH, Karstedt SC, Münte TF, Göbel H, Wolfrum S, Lebedeva ER, Olesen J, Royl G. ICHD-3 is significantly more specific than ICHD-3 beta for diagnosis of migraine with aura and with typical aura. J Headache Pain. 2020 Jan 7;21(1):2. (2++)
26 Göbel H, Heinze A, Heinze-Kuhn K, Göbel CHH. Moderne Migränetherapie – fachübergreifende Versorgung im Langzeitverlauf [Modern migraine therapy-interdisciplinary long-term care]. Internist (Berl). 2020 Mar;61(3):326-332. (4-)
27 Hadjikhani N, Sanchez Del Rio M, Wu O, Schwartz D, Bakker D, Fischl B, Kwong KK, Cutrer FM, Rosen BR, Tootell RB, Sorensen AG, Moskowitz MA. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4687-92. (2+)
28 Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211.
29 Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211. (4-)
30 https://ichd-3.org (abgerufen am 18.04.2024)
31 https://www.bfarm.de/SharedDocs/Risikoinformationen/Pharmakovigilanz/DE/RHB/2023/rhb-topiramat.html (abgerufen 18.04.2024) (2++)
32 https://www.bfarm.de/SharedDocs/Risikoinformationen/Pharmakovigilanz/DE/RHB/2024/rhb-valproat.html (2++)
33 https://www.bmas.de/SharedDocs/Downloads/DE/Publikationen/k710-versorgungsmed-verordnung.pdf (abgerufen am 18.04.2024)
34 https://www.embryotox.de/arzneimittel/details/ansicht/medikament/metoprolol (abgerufen am 20.04.2024) (3-)
35 https://www.embryotox.de/arzneimittel/details/ansicht/medikament/propranolol (abgerufen am 20.04.2024) (3-)
36 ICD-10-GM Version 2021, Systematisches Verzeichnis, Internationale statisti-sche Klassifikation der Krankheiten und verwandter Gesundheitsprobleme, 10. Revision, Stand: 18. September 2020, https://www.icd-code.de (abgerufen 18.04.2024)
37 Ishii R, Schwedt TJ, Kim SK, Dumkrieger G, Chong CD, Dodick DW. Effect of Mi-graine on Pregnancy Planning: Insights From the American Registry for Migraine Research. Mayo Clin Proc. 2020 Oct;95(10):2079-2089. (2+)
38 Jenabi E, Khazaei S. Endometriosis and migraine headache risk: a meta-analysis. Women Health. 2020 Sep;60(8):939-945. (1++)
39 Jette N, Patten S, Williams J, Becker W, Wiebe S. Comorbidity of migraine and psychiatric disorders--a national population-based study. Headache. 2008 Apr;48(4):501-16. (2++)
40 Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE. Migraine and risk of cardiovascular disease in women. JAMA. 2006 Jul 19;296(3):283-91. (2++)
41 Kuruvilla A, Bhattacharya P, Rajamani K, Chaturvedi S. Factors associated with misdiagnosis of acute stroke in young adults. J Stroke Cerebrovasc Dis. 2011;20(6):523–527. (2+)
42 Lampl C, Thomas H, Tassorelli C, Katsarava Z, Laínez JM, Lantéri-Minet M, Rastenyte D, Ruiz de la Torre E, Stovner LJ, Andrée C, Steiner TJ. Headache, depression and anxiety: associations in the Eurolight project. J Headache Pain. 2016;17:59. (2+)
43 Lauritzen M, Olesen J. Regional cerebral blood flow during migraine attacks by Xenon-133 inhalation and emission tomography. Brain. 1984 Jun;107 ( Pt 2):447-61.  (2+)
44 Lebedeva ER, Gurary NM, Gilev DV, Christensen AF, Olesen J. Explicit diagnostic criteria for transient ischemic attacks to differentiate it from migraine with aura. Cephalalgia. 2018 Jul;38(8):1463-1470. (2++)
45 Leppert MH, Poisson SN, Scarbro S, Suresh K, Lisabeth LD, Putaala J, Schwamm LH, Daugherty SL, Bradley CJ, Burke JF, Ho PM. Association of Traditional and Nontraditional Risk Factors in the Development of Strokes Among Young Adults by Sex and Age Group: A Retrospective Case-Control Study. Circ Cardiovasc Qual Outcomes. 2024 Apr;17(4):e010307. (2++)
46 MacClellan LR, Giles W, Cole J, Wozniak M, Stern B, Mitchell BD, Kittner SJ. Probable migraine with visual aura and risk of ischemic stroke: the stroke pre-vention in young women study. Stroke. 2007 Sep;38(9):2438-45. (2++)
47 MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A. Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study. Neuro-logy. 2006 Dec 26;67(12):2159-63. (1++)
48 Nappi RE, Tiranini L, Sacco S, De Matteis E, De Icco R, Tassorelli C. Role of Estro-gens in Menstrual Migraine. Cells. 2022 Apr 15;11(8):1355. (1++)
49 Natoli JL, Manack A, Dean B, Butler Q, Turkel CC, Stovner L, Lipton RB. Global prevalence of chronic migraine: a systematic review. Cephalalgia. 2010 May;30(5):599-609.  (1++)
50 Ornello R, Caponnetto V, Frattale I, Sacco S. Patterns of Migraine in Postmeno-pausal Women: A Systematic Review. Neuropsychiatr Dis Treat. 2021 Mar 19;17:859-871. (2++)
51 Ornello R, Frattale I, Caponnetto V, De Matteis E, Pistoia F, Sacco S. Menstrual Headache in Women with Chronic Migraine Treated with Erenumab: An Observa-tional Case Series. Brain Sci. 2021 Mar 13;11(3):370. (2+)
52 Pavlovic JM, Paemeleire K, Göbel H, Bonner J, Rapoport A, Kagan R, Zhang F, Picard H, Mikol DD. Efficacy and safety of erenumab in women with a history of menstrual migraine. J Headache Pain. 2020 Aug 3;21(1):95. (1+)
53 Pavlović JM, Allshouse AA, Santoro NF, Crawford SL, Thurston RC, Neal-Perry GS, Lipton RB, Derby CA. Sex hormones in women with and without migraine: Evi-dence of migraine-specific hormone profiles. Neurology. 2016 Jul 5;87(1):49-56. (2++)
54 Purdue-Smithe AC, Stuart JJ, Farland LV, Kang JH, Harriott AM, Rich-Edwards JW, Rexrode K. Prepregnancy Migraine, Migraine Phenotype, and Risk of Adverse Pregnancy Outcomes. Neurology. 2023 Apr 4;100(14):e1464-e1473.  (2++)
55 Radtke A, Neuhauser H. Prevalence and burden of headache and migraine in Germany. Headache. 2009 Jan;49(1):79-89. (2++)
56 Russell MB. Genetics of menstrual migraine: the epidemiological evidence. Curr Pain Headache Rep. 2010 Oct;14(5):385-8. (1++)
57 Sacco S, Merki-Feld GS, Ægidius KL, Bitzer J, Canonico M, Kurth T, Lampl C, Lide-gaard Ø, Anne MacGregor E, MaassenVanDenBrink A, Mitsikostas DD, Nappi RE, Ntaios G, Sandset PM, Martelletti P; European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). J Headache Pain. 2017 Oct 30;18(1):108. doi: 10.1186/s10194-017-0815-1. Erratum in: J Headache Pain. 2018 Sep 10;19(1):81. (1++)
58 Sacco S, Merki-Feld GS, Ægidius KL, Bitzer J, Canonico M, Kurth T, Lampl C, Lidegaard Ø, Anne MacGregor E, MaassenVanDenBrink A, Mitsikostas DD, Nappi RE, Ntaios G, Sandset PM, Martelletti P; European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). J Headache Pain. 2017 Oct 30;18(1):108. doi: 10.1186/s10194-017-0815-1. Erratum in: J Headache Pain. 2018 Sep 10;19(1):81. (1++)
59 Sacco S, Merki-Feld GS, Ægidius KL, Bitzer J, Canonico M, Kurth T, Lampl C, Lidegaard Ø, Anne MacGregor E, MaassenVanDenBrink A, Mitsikostas DD, Nappi RE, Ntaios G, Sandset PM, Martelletti P; European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). J Headache Pain. 2017 Oct 30;18(1):108. doi: 10.1186/s10194-017-0815-1. Erratum in: J Headache Pain. 2018 Sep 10;19(1):81. (4-)
60 Safiri S, Pourfathi H, Eagan A, Mansournia MA, Khodayari MT, Sullman MJM, Kaufman J, Collins G, Dai H, Bragazzi NL, Kolahi AA. Global, regional, and national burden of migraine in 204 countries and territories, 1990 to 2019. Pain. 2022 Feb 1;163(2):e293-e309. (1++)
61 Sances G, Granella F, Nappi RE, Fignon A, Ghiotto N, Polatti F, Nappi G. Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia. 2003 Apr;23(3):197-205 (2+)
62 Shughrue PJ, Merchenthaler I. Estrogen is more than just a "sex hormone": novel sites for estrogen action in the hippocampus and cerebral cortex. Front Neuro-endocrinol. 2000 Jan;21(1):95-101. (1++)
63 Skajaa N, Szépligeti SK, Xue F, Sørensen HT, Ehrenstein V, Eisele O, Adelborg K. Pregnancy, Birth, Neonatal, and Postnatal Neurological Outcomes After Preg-nancy With Migraine. Headache. 2019 Jun;59(6):869-879. (2++)
64 Somerville BW. The role of estradiol withdrawal in the etiology of menstrual mi-graine. Neurology. 1972 Apr;22(4):355-65. (2+)
65 Stovner LJ, Hagen K, Linde M, Steiner TJ. The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates. J Headache Pain. 2022 Apr 12;23(1):34. (1++)
66 Tassorelli C, Sandrini G, Cecchini AP, Nappi RE, Sances G, Martignoni E. Chang-es in nociceptive flexion reflex threshold across the menstrual cycle in healthy women. Psychosom Med. 2002 Jul-Aug;64(4):621-6. (2+)
67 Terrin A, Toldo G, Ermani M, Mainardi F, Maggioni F. When migraine mimics stroke: A systematic review. Cephalalgia. 2018 Dec;38(14):2068-2078. (1++)
68 Thomsen AV, Ashina H, Al-Khazali HM, Rose K, Christensen RH, Amin FM, Ashina M. Clinical features of migraine with aura: a REFORM study. J Headache Pain. 2024 Feb 13;25(1):22. (2+)
69 Torres-Ferrús M, Ursitti F, Alpuente A, Brunello F, Chiappino D, de Vries T, Di Marco S, Ferlisi S, Guerritore L, Gonzalez-Garcia N, Gonzalez-Martinez A, Khuto-rov D, Kritsilis M, Kyrou A, Makeeva T, Minguez-Olaondo A, Pilati L, Serrien A, Tsurkalenko O, Van den Abbeele D, van Hoogstraten WS, Lampl C; School of Advanced Studies of European Headache Federation (EHF-SAS). From transfor-mation to chronification of migraine: pathophysiological and clinical aspects. J Headache Pain. 2020 Apr 29;21(1):42. (1++)
70 Vetvik KG, MacGregor EA. Menstrual migraine: a distinct disorder needing great-er recognition. Lancet Neurol. 2021 Apr;20(4):304-315. (1++)
71 Wolf ME, Szabo K, Griebe M, Förster A, Gass A, Hennerici MG, Kern R. Clinical and MRI characteristics of acute migrainous infarction. Neurology. 2011 May 31;76(22):1911-7. (2+)
72 www.rki.de/DE/Content/Gesundheitsmonitoring/Gesundheitsberichterstattung/GBEDownloadsJ/JoHM_S6_2020_Migraene_Spannungskopfschmerz.pdf (abgeru-fen am 19.04.2024) (2++)